Log In
Print this Print this

neostigmine methylsulfate (Bloxiverz)

  Manage Alerts
Collapse Summary General Information
Company Avadel Pharmaceuticals plc
DescriptionCholinesterase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard Indication Neurology (unspecified)
Indication DetailsReverse the effects of non-depolarizing neuromuscular blocking agents after surgery
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today